After retreating almost 27% in Q3, the Canadian Cannabis LP Index extended its losing streak to five months as it fell again in November, declining 5.5.% to 225.26:

The index, which fell 30.1% in 2020 to end at 275.16, is down 22% over the past year and down 18.1% year-to-date in 2021:

It remains substantially below the all-time closing high of 1314.33 in September 2018, just ahead of Canadian adult-use legalization. In March 2020, it posted a new 52-week closing low of 196.10, a level not seen since late 2016, and it closed 14.9% above that level at the end of November:

It has been more than three years since Canada legalized recreational marijuana on Oct. 17, 2018. The road has been a bumpy one for the industry as supply issues and rising competition have made it challenging for cannabis companies in the country to grow their sales or post a profit.

The industry leader three years ago was cannabis producer Canopy Growth (NASDAQ: CGC), but it's clear it isn't in that place right now as rival Tilray generates more in revenue. A lot has changed since legalization took place, and if you were to bet that legalization would have been the opportune time to invest in Canopy Growth, you would be sorely disappointed.

A legal, regulated approach would divert costs from the criminal justice system. Those savings could be used for community health and harm reduction.

It is distressing that the toxic drug poisoning deaths of more than 22,000 Canadians were not a bigger issue in the recent federal election, especially when government policy is a driving factor behind those preventable deaths. The newly created federal Ministry of Mental Health and Addictions must take steps toward securing the life, liberty and security of people who use drugs and ending the overdose crisis. The action needed from this new ministry is clear.

Beena Goldenberg is approaching 90 days as the CEO of Organigram (NASDAQ: OGI) (TSX: OGI). While some other Canadian LPs are shutting down facilities, Organigram is in the process of expanding to keep up with customer demand. Goldenberg spoke with New Cannabis Ventures about the company’s current momentum, the British American Tobacco (BAT) investment and the company’s cash position. The audio of the entire conversation is available at the end of this written summary.

Recent testing shows cannabis strain with 35 per cent THC virtually stink-free.

Canadian company CannabCo. Pharmaceutical Corp. (CannabCo.) has high hopes for the future with Tuesday announcement that it has used its proprietary technology to slash the smell of a high-THC strain.

“Working with regulators, we look forward to establishing tools to create a stronger foundation of analytical methods for psychedelic compounds and products.”

Vancouver-based Numinus Wellness has announced the development of proprietary methods for testing and screening psychedelic mushroom compounds.

Greenway Greenhouse released its first-quarter financial statements since hitting markets in September.

Revenue came in at C$1.15 million ($906,547), with gross profit before fair value adjustments at C$532,263.  

For Al Harrington, who played his last NBA game in Toronto in 2014, the partnership offers another reason to return north, though this time with a different purpose.

Aras Azadian, the CEO of Avicanna, a multinational cannabis and biopharmaceutical company, is waiting in line at the passport office when he takes a call from The GrowthOp.

Having recently returned from Mexico, where his passport was stolen, he’s got a day to resolve the situation before heading off again to Brazil.

Canada House Wellness Group (CSE: CHV) ("Canada House" or the "Company"), a fully integrated medical cannabis company, is pleased to announce the achievement of several company milestones as it works towards the completion of the previously announced reverse takeover (RTO) of the Company by Montréal Cannabis Médical Inc. ("MTL Cannabis") (the "Transaction").  The Transaction is now expected to close in calendar Q1 2022, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals and the shareholder approval described below.

Canada's main stock index reversed early losses to close higher on Wednesday following choppy trading, as growth sectors including technology and cannabis rose, offsetting declines in utilities and materials.The Toronto Stock Exchange's S&P/TSX composite index closed up 94.66 points, or 0.4%, at 21,548.43, led by technology and healthcare, whichrose 1.8% and 1.7%, respectively.

Cloud-based learning management provider Docebo Inc (DCBO.TO) was the biggest gainer, rising 6%, with Lightspeed Commerce (LSPD.TO) and Shopify Inc (SHOP.TO) also among the top 10 stocks on the index.